reversal occurring in regenerson after quite a sustained correction.
Historical buy signal is complete on the weekly chart, the is a little overbought so we await a break in the weekly for a safer entry.
Average analysts price target $383 | Overweight.
Regeneron Pharmaceuticals , Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines . It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
1) Sign Up for our Free Email Newsletter @
2) Sign Up for our Free Text Message Notifications
by Texting 'GAINS' to 67076.
(*It's FREE, however Msg&Data rates may apply